HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
5-methoxy-3-(di-n-propylamino)chroman
labels central 5-HT receptor binding sites
Also Known As:
5-MeO-DPAC; 5-methoxy-3-(dipropylamino)chroman
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
1-Ring Heterocyclic Compounds
Pyrans: 130
Benzopyrans: 195
Chromans: 3
5-methoxy-3-(di-n-propylamino)chroman: 1
Fused-Ring Heterocyclic Compounds
2-Ring Heterocyclic Compounds
Benzopyrans: 195
Chromans: 3
5-methoxy-3-(di-n-propylamino)chroman: 1
Related Diseases
1.
Lordosis
07/01/1993 - "
Serotonin (2000 ng) and the 5-HT1A agonists, 8-hydroxy-2-(di-n-propylamino)tetralin [8-OH-DPAT (200 ng)], 5-methoxy-3-(di-n-propylamino)chroman [5-MEO-DPAC (200-2000 ng)] and 5-hydroxy-3-(N-di-n-propylamino)chroman [5-OH-DPAC (200-2000 ng)] inhibited female lordosis behavior within 10 min of the infusion.
"
Related Drugs and Biologics
1.
8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)
2.
Serotonin (5 Hydroxytryptamine)
3.
3-propylamino-5-hydroxychroman
4.
hydroxide ion